Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Cuban embassy attacked
Accused of ‘fraud’
'He'll do it again'
'I'm at a loss for words'
Not her biological father
Italian Mafia boss dies
Dead woman in gator's jaws
Can detect human emotions?
A 'savage' performance
Pleads guilty to drunk driving
Calif. beach shut down
US immigration court system
Team World wins Laver Cup
Lahaina families set to return
UKR drone strikes Kursk
China coal mine fire kills 16
Dolphins honor slain deputy
Mayor Bass honored
Storm Ophelia still a risk
Stroud makes history
Terry Kirkman dies
Accuses Jones of cheap shot
Loren undergoes surgery
To invest $4B in Anthropic
Ice cream products recalled
Oakland's auto theft epidemic
Mo. AG sues health provider
Jackpot soars to $785M
Eliminated from playoff race
$1.4B for fixes, upgrades
S. Korea, US hold joint drills
Evaluated for concussion
Fastest 25K passing yards
Wins approval in Japan
'It never gets easier'
Suffers knee injury
Kidnapped teen rescued
Clyburn hedges on Harris
Surprises street musician
2000-yr-old cemetery in Gaza
Tickets sold for $262,500
Tear gas to disperse rioters
House speaker apologizes
Bowden gets engaged
Woman dies in 150-foot fall
Threatened by climate change
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
226,000 results
22m
FDA skeptical of experimental ALS treatment pushed by patient advocates
On Wednesday, researchers will tell FDA that because many patients declined so quickly on the scale, the study failed to show ...
朝日新聞社29d
FDA approves much-debated Alzheimer’s drug panned by experts
FDA approves much-debated Alzheimer’s drug panned by experts THE ASSOCIATED PRESS June 8, 2021 at 09:15 JST Share Tweet list Print In this 2019 photo provided by Biogen, a researcher works on ...
朝日新聞社10d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
The Courier-Journal5d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Afro13d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
Daily Trojan13d
The USC researchers behind a newly approved treatment for Alzheimer’s
USC researchers played a key role in a new treatment for Alzheimer’s disease, the first with full approval to target a suspected root cause of the condition, offering hope to those with the disease ...
Salon11d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
Scientific American5d
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet. Josh Fischman: We bring you the latest vital health news: Discoveries that affect ...
Washington Monthly
13d
As Dementia Cases Soar, Who Will Care for the Caregivers?
A CMS pilot project will test a low-cost way to help families support a suffering loved one. It’s more promising than ...
BioPharma Dive
13d
New startup Arialys takes aim at the immune system, hoping to create neuropsychiatry drugs
Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.
Ravalli Republic
13d
FDA approves updated COVID vaccines to rev up protection this fall
The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and ...
Scientific American5d
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet. Josh Fischman: We bring you the latest vital health news: Discoveries that affect ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices